R. Puri

发表

Proposed low-density lipoprotein cholesterol goals for secondary prevention and familial hypercholesterolemia in India with focus on PCSK9 inhibitor monoclonal antibodies: Expert consensus statement from Lipid Association of India.

Sundeep Mishra, N. N. Khanna, R. Kasliwal, 2020, Journal of clinical lipidology.

The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP).

A. Khera, D. Panagiotakos, J. Jozwiak, 2020, Clinical nutrition.

Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action.

C. Aguilar-Salinas, G. Mensah, G. Watts, 2020, JAMA cardiology.

When is it Appropriate to Lower Low Density Lipoprotein-Cholesterol Levels to <30 mg/dL?

N. Wong, P. Duell, R. Puri, 2021, The American journal of cardiology.

Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel

M. Banach, N. Wong, K. Kostner, 2015, Expert opinion on drug safety.

The epidemic of atherosclerotic cardiovascular disease in India.

P. Duell, D. Nair, R. Puri, 2020, Journal of clinical lipidology.

Letter by Puri et al Regarding Article, "Reductions in Atherogenic Lipids and Major Cardiovascular Events: A Pooled Analysis of 10 ODYSSEY Trials Comparing Alirocumab With Control".

R. Puri, S. Puri, Anil Rajani, 2017, Circulation.

Evidence for intensive LDL-C lowering for acute coronary syndrome: Recommendations from the Lipid Association of India.

R. Kasliwal, A. Muruganathan, R. Aggarwal, 2022, Journal of clinical lipidology.

Unmet Need for Further LDL-C Lowering in India despite Statin Therapy: Lipid Association of India Recommendations for the Use of Bempedoic Acid.

N. N. Khanna, R. Kasliwal, A. Muruganathan, 2022, The Journal of the Association of Physicians of India.

World Heart Federation Cholesterol Roadmap 2022

S. Gidding, W. Almahmeed, P. Perel, 2022, Global heart.

Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel

M. Banach, N. Wong, K. Kostner, 2015, Expert opinion on drug safety.

Management of diabetic dyslipidemia in Indians: Expert consensus statement from the Lipid Association of India.

A. Sahoo, A. Zargar, S. Kalra, 2022, Journal of clinical lipidology.

Lipid Association of India (LAI) expert consensus statement on management of dyslipidaemia in Indians 2017: part 2

S. Seth, N. N. Khanna, R. Kasliwal, 2017 .

Lipid Association of India Expert Consensus Statement on Management of Dyslipidemia in Indians 2016: Part 1 - Executive summary

Rajendra Singh Rajput, K. Seshadri, R. Kasliwal, 2016, The Journal of the Association of Physicians of India.

Seasonal epidemic of ocular caterpillar hair injuries in the Kangra District of India

R. Puri, R. Tuli, Rattan Sharma, 2004, Ophthalmic epidemiology.

Genetic analysis of familial hypercholesterolemia in Asian Indians: A single-center study.

R. Saxena, Sanghamitra Mishra, Sanika Apte, 2020, Journal of clinical lipidology.

Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)

A. Khera, D. Panagiotakos, J. Jozwiak, 2022, Journal of cachexia, sarcopenia and muscle.

Prevention of atherosclerotic cardiovascular disease in South Asians in the US: A clinical perspective from the National Lipid Association.

Alan S. Brown, P. Joshi, N. Desai, 2021, Journal of clinical lipidology.

Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel

M. Banach, N. Wong, K. Kostner, 2015, Expert opinion on drug safety.

Randomized controlled trial comparing the efficacy of daily and every other day atorvastatin therapy and its correlation with serum hydroxymethylglutaryl-CoA reductase enzyme levels in naïve dyslipidemic patients

M. Kumar, L. Gupta, H. Rehan, 2018, Indian heart journal.

South Asians: why are they at a higher risk for cardiovascular disease?

D. Nair, R. Puri, R. Puri, 2017, Current opinion in cardiology.

Low Density Lipoprotein Cholesterol Targets in Secondary Prevention of Atherosclerotic Cardiovascular Disease.

N. Wong, Sundeep Mishra, A. Zargar, 2020, The Journal of the Association of Physicians of India.

The Indian consensus statement for the management of lower extremity peripheral artery disease

N. N. Khanna, S. Wangnoo, R. Vijayvergiya, 2023, Journal of Indian College of Cardiology.

Lipid association of India expert consensus statement on management of dyslipidemia in Indians 2016 - part 1

R. Puri, S. Narasingan, S. Iyengar, 2016, The Journal of the Association of Physicians of India.

Evidence regarding SGLT-2 inhibitors for the management of diabetic dyslipidemia

P. Duell, R. Puri, V. Mehta, 2023, Journal of Clinical Lipidology.

Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel

W. Aronow, J. Rysz, Z. Fras, 2015, Archives of medical science : AMS.

PREVALENCE AND PATTERN OF DYSLIPIDEMIA IN 2500 ADOLESCENTS IN SUBURBAN INDIA

H. Rehan, R. Puri, S. Puri, 2015 .

Non-HDL Cholesterol and Atherosclerotic Cardiovascular Disease.

N. Wong, Sundeep Mishra, A. Zargar, 2020, The Journal of the Association of Physicians of India.

Lipid Association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients: Consensus statement IV.

R. Kasliwal, B. Saboo, P. Duell, 2024, Journal of clinical lipidology.